Dr. Lal Path Labs Ltd
American Funds (Capital Group) increased its stake in Dr. Lal Path Labs Ltd from 1.42% to 1.98%, buying 946,108 shares worth ₹160.74 Cr.
A leading diagnostic services provider in India, Dr. Lal PathLabs operates an integrated nationwide network delivering laboratory tests and comprehensive healthcare services. The company serves individual patients, hospitals, healthcare providers, and corporate clients through core diagnostic testing, disease diagnosis, prevention, monitoring, and treatment support. Its distinctive strength lies in combining consumer accessibility with a broad range of diagnostic capabilities and related health services across the country.
India equity holdings of American Funds, the mutual fund family of Capital Group. Long-only, fundamentally driven strategy.